Royce & Associates LP Dynavax Technologies Corp Transaction History

Royce & Associates LP

  • $10.5 Billion
  • Q3 2024

A detailed history of Royce & Associates LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Royce & Associates LP holds 374,119 shares of DVAX stock, worth $4.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
374,119
Previous 395,682 5.45%
Holding current value
$4.8 Million
Previous $4.44 Million 6.21%
% of portfolio
0.04%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$10.05 - $11.61 $216,708 - $250,346
-21,563 Reduced 5.45%
374,119 $4.17 Million
Q2 2024

Aug 13, 2024
SELL
$10.73 - $12.58 $290,385 - $340,452
-27,063 Reduced 6.4%
395,682 $4.44 Million
Q1 2024

May 13, 2024
SELL
$11.7 - $14.98 $85,725 - $109,758
-7,327 Reduced 1.7%
422,745 $5.25 Million
Q4 2023

Feb 12, 2024
SELL
$13.09 - $14.98 $93,868 - $107,421
-7,171 Reduced 1.64%
430,072 $6.01 Million
Q3 2023

Nov 09, 2023
SELL
$12.64 - $14.99 $63,376 - $75,159
-5,014 Reduced 1.13%
437,243 $6.46 Million
Q2 2023

Aug 07, 2023
BUY
$9.85 - $13.17 $30,249 - $40,445
3,071 Added 0.7%
442,257 $5.71 Million
Q1 2023

May 04, 2023
BUY
$9.44 - $11.88 $324,169 - $407,959
34,340 Added 8.48%
439,186 $4.31 Million
Q4 2022

May 23, 2023
SELL
$10.27 - $13.29 $352,671 - $456,378
-34,340 Reduced 7.82%
404,846 $4.31 Million
Q4 2022

Feb 13, 2023
BUY
$10.27 - $13.29 $861,036 - $1.11 Million
83,840 Added 26.12%
404,846 $4.31 Million
Q3 2022

Nov 03, 2022
BUY
$9.93 - $17.44 $301,435 - $529,408
30,356 Added 10.44%
321,006 $3.35 Million
Q2 2022

Aug 04, 2022
SELL
$7.45 - $12.83 $16,263 - $28,007
-2,183 Reduced 0.75%
290,650 $3.66 Million
Q1 2022

May 05, 2022
BUY
$9.75 - $14.44 $4,221 - $6,252
433 Added 0.15%
292,833 $3.17 Million
Q4 2021

Feb 07, 2022
SELL
$13.17 - $20.94 $263,400 - $418,800
-20,000 Reduced 6.4%
292,400 $4.11 Million
Q3 2021

Nov 10, 2021
SELL
$9.16 - $19.83 $681,504 - $1.48 Million
-74,400 Reduced 19.23%
312,400 $6 Million
Q2 2020

Aug 07, 2020
SELL
$2.94 - $9.1 $94,374 - $292,110
-32,100 Reduced 7.66%
386,800 $3.43 Million
Q1 2020

May 12, 2020
BUY
$2.27 - $6.2 $268,768 - $734,080
118,400 Added 39.4%
418,900 $1.48 Million
Q4 2019

Feb 06, 2020
BUY
$3.46 - $6.93 $34,600 - $69,300
10,000 Added 3.44%
300,500 $1.72 Million
Q3 2019

Nov 13, 2019
BUY
$2.69 - $4.85 $421,792 - $760,480
156,800 Added 117.28%
290,500 $1.04 Million
Q2 2019

Aug 12, 2019
SELL
$3.65 - $7.89 $311,710 - $673,806
-85,400 Reduced 38.98%
133,700 $533,000
Q4 2018

Feb 11, 2019
BUY
$8.14 - $13.28 $1.78 Million - $2.91 Million
219,100 New
219,100 $2.01 Million

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.62B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email